Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Olson

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2020
Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate CancerChristos E Kyriakopoulos, Jens C Eickhoff, Anna C Ferrari, et al.
Cancer Immunology Research|October 21, 2017
Prostate Cancer Cells Express More Androgen Receptor (AR) Following Androgen Deprivation, Improving Recognition by AR-Specific T CellsBrian M Olson, Melissa Gamat, Joseph Seliski, et al.
Molecular Cancer Therapeutics|April 4, 2023
BET Inhibition Sensitizes Immunologically Cold Rb-Deficient Prostate Cancer to Immune Checkpoint BlockadeBrian M Olson, Kiranj Chaudagar, Riyue Bao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014
Real-time immune monitoring to guide plasmid DNA vaccination schedule targeting prostatic acid phosphatase in patients with castration-resistant prostate cancerDouglas G McNeel, Jordan T Becker, Jens C Eickhoff, et al.
The Prostate|February 10, 2017
Safety and Immunological Efficacy of a DNA Vaccine Encoding the Androgen Receptor Ligand-Binding Domain (AR-LBD)Brian M Olson, Eric S Bradley, Thomas Sawicki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract CancerAmanda N Ruggieri, Mark Yarchoan, Subir Goyal, et al.
Molecular Cancer Therapeutics|October 10, 2020
Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic CancerYuchen Zhang, Michael B Ware, Mohammad Y Zaidi, et al.
Cancer Discovery|March 10, 2017
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate ImmunityAkash Patnaik, Kenneth D Swanson, Eva Csizmadia, et al.
Nature Cancer|April 26, 2021
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerKatherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2020
Multicenter Phase I Trial of a DNA Vaccine Encoding the Androgen Receptor Ligand-binding Domain (pTVG-AR, MVI-118) in Patients with Metastatic Prostate CancerChristos E Kyriakopoulos, Jens C Eickhoff, Anna C Ferrari, et al.
Cancer Immunology Research|October 21, 2017
Prostate Cancer Cells Express More Androgen Receptor (AR) Following Androgen Deprivation, Improving Recognition by AR-Specific T CellsBrian M Olson, Melissa Gamat, Joseph Seliski, et al.
Molecular Cancer Therapeutics|April 4, 2023
BET Inhibition Sensitizes Immunologically Cold Rb-Deficient Prostate Cancer to Immune Checkpoint BlockadeBrian M Olson, Kiranj Chaudagar, Riyue Bao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014
Real-time immune monitoring to guide plasmid DNA vaccination schedule targeting prostatic acid phosphatase in patients with castration-resistant prostate cancerDouglas G McNeel, Jordan T Becker, Jens C Eickhoff, et al.
The Prostate|February 10, 2017
Safety and Immunological Efficacy of a DNA Vaccine Encoding the Androgen Receptor Ligand-Binding Domain (AR-LBD)Brian M Olson, Eric S Bradley, Thomas Sawicki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract CancerAmanda N Ruggieri, Mark Yarchoan, Subir Goyal, et al.
Molecular Cancer Therapeutics|October 10, 2020
Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic CancerYuchen Zhang, Michael B Ware, Mohammad Y Zaidi, et al.
Cancer Discovery|March 10, 2017
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate ImmunityAkash Patnaik, Kenneth D Swanson, Eva Csizmadia, et al.
Nature Cancer|April 26, 2021
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerKatherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.
Pageof 3